Rani Therapeutics Holdings, Inc. (RANI) Q1 2025 Annual Earnings
RANI·Reported May 13, 2025·Before market open
Rani Therapeutics Holdings, Inc. reported Q1 2025 revenue of $172.0K. Diluted EPS came in at $-0.22 (+24.1% YoY).
Revenue
$172.0K
Diluted EPS
$-0.22met estimate
Consensus: $-0.22
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Rani Therapeutics Holdings, Inc.'s Q1 2025 earnings report.
Rani Therapeutics Holdings, Inc. (RANI) reported Q1 2025 earnings on May 13, 2025 before market open.
Rani Therapeutics Holdings, Inc. reported revenue of $172.0K and diluted EPS of $-0.22 for Q1 2025.
EPS beat the consensus estimate of $-0.22 by $0.00.
Compared to the same quarter a year prior, diluted EPS grew 24.1% from $-0.29.
You can read the 10-K periodic report (0000950170-25-047740) directly on SEC EDGAR. The filing index links above go to sec.gov.